BIOMAT Database Logo BIOMAT Database Logo

Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates. 1984

H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa

The bioavailability of nalidixic acid in beagles was determined using the same tablet formulations previously tested on humans and was compared with bioavailability in humans and with in vitro dissolution rates. The beagle bioavailability test provided lower power in all of the bioavailability parameters than did the human test. Tmax of the tablets did not greatly differ in beagles, although in humans a wide variation of Tmax was seen. A linearity between Cmax and AUC0-infinity was observed in beagles, but Tmax did not show a linearity with Cmax or AUC in dogs, which is quite different from the relations observed in humans. The rank order of tablets according to Cmax was exactly the same between humans and beagles. AUC also showed the same rank order between humans and beagles except for on tablet with a poor disintegrating ability. A significant correlation between human and beagle Cmax values was obtained (r = 0.8952; p less than 0.05), but not between human and beagle AUC and Tmax values.

UI MeSH Term Description Entries
D009268 Nalidixic Acid A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. Nalidixin,Nalidixate Sodium,Nalidixate Sodium Anhydrous,Nevigramon,Sodium Nalidixic Acid, Anhydrous,Sodium Nalidixic Acid, Monohydrate,Acid, Nalidixic,Anhydrous, Nalidixate Sodium,Sodium Anhydrous, Nalidixate,Sodium, Nalidixate
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
July 2009, Pakistan journal of pharmaceutical sciences,
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
Correlation of dissolution, disintegration, and bioavailability of aminosalicylic acid tablets.
August 1973, Journal of pharmaceutical sciences,
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
Dissolution-rates and bioavailability of digoxin tablets.
June 1973, Lancet (London, England),
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
Bioequivalence study of nalidixic acid tablets: in vitro-in vivo correlation.
July 1993, Biopharmaceutics & drug disposition,
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
Comparison of in vitro dissolution and in vivo bioavailability of methaqualone tablets in humans.
September 1978, Journal of pharmaceutical sciences,
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
December 1993, Die Pharmazie,
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
[Improved bioavailability of Israeli digoxin tablets with increased dissolution rates].
October 1977, Harefuah,
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
[Correlation between in vitro dissolution characteristics of macrolide antibiotic tablets and bioavailability in man].
September 1987, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
August 1980, Die Pharmazie,
H Ogata, and N Aoyagi, and N Kaniwa, and T Shibazaki, and A Ejima, and N Takasugi, and E Mafune, and T Hayashi, and K Suwa
Bioavailability of aminosalicylic acid and its various salts in humans. 3. Absorption from tablets.
May 1974, Journal of pharmaceutical sciences,
Copied contents to your clipboard!